Mark Wong
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Alkaloids: synthesis and pharmacology
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 18
- Colorectal Cancer Treatments and Studies 8
- Cancer Immunotherapy and Biomarkers 5
- Cancer Treatment and Pharmacology 2
- Drug Transport and Resistance Mechanisms 2
-
- Genetic factors in colorectal cancer 5
- Co-authors
- Howard Gurney (8 shared papers)Bavanthi Balakrishnar (6 shared papers)Bo Gao (4 shared papers)Arthur Clements (1 shared paper)Massimo Aglietta (6 shared papers)Eric Van Cutsem (6 shared papers)Michael J. Overman (6 shared papers)Fabio Gelsomino (5 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)The Breast (2 papers)Clinical Cancer Research (1 paper)Neuro-Oncology (1 paper)Hepatology (1 paper)
- Partner nations
- AustraliaUnited StatesItaly
In The Last Decade
Mark Wong
26 papers receiving 668 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 121
- Oncology 324
- Genetics 70
- Biochemistry 44
- Pathology and Forensic Medicine 85
Countries citing papers authored by Mark Wong
This map shows the geographic impact of Mark Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wong more than expected).
Fields of papers citing papers by Mark Wong
This network shows the impact of papers produced by Mark Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wong. The network helps show where Mark Wong may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Wong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 161 | |
| 2 | 2016 | 64 | |
| 3 | 2014 | 55 | |
| 4 | 2018 | 53 | |
| 5 | 2006 | 47 | |
| 6 | 2013 | 43 | |
| 7 | 2016 | 41 | |
| 8 | 2018 | 38 | |
| 9 | 2024 | 34 | |
| 10 | 2020 | 32 | |
| 11 | 2022 | 25 | |
| 12 | 2013 | 23 | |
| 13 | 2012 | 14 | |
| 14 | 2015 | 13 | |
| 15 | 2019 | 11 | |
| 16 | 2023 | 4 | |
| 17 | 2024 | 4 | |
| 18 | 2020 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2021 | 2 |
About Mark Wong
Mark Wong is a scholar working on Oncology, Pathology and Forensic Medicine, Surgery, Pulmonary and Respiratory Medicine and Epidemiology, having authored 27 papers that have together received 679 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Immunotherapy and Biomarkers (5 papers), Genetic factors in colorectal cancer (5 papers), Cancer Treatment and Pharmacology (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Colorectal and Anal Carcinomas (2 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Pharmacology (121 citations), Oncology (324 citations), Genetics (70 citations), Biochemistry (44 citations) and Pathology and Forensic Medicine (85 citations). Mark Wong has collaborated with scholars based in Australia, United States and Italy. Frequent co-authors include Howard Gurney, Bavanthi Balakrishnar, Bo Gao, Arthur Clements, Massimo Aglietta, Eric Van Cutsem, Michael J. Overman, Fabio Gelsomino, Rosemary L. Balleine and Bart Neyns. Their work appears in journals such as Journal of Clinical Oncology, The Breast, Clinical Cancer Research, Neuro-Oncology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.